Intrathecal baclofen in cerebral palsy. A retrospective study of 25 wheelchair-assisted adults;Baclofene intrathecal dans la paralysie cerebrale. Étude rétrospective de 25 patients adultes non marchants.

Annals of Physical and Rehabilitation Medicine

Volumn 53, Issue 8, 2010, Pages 483-498

  Tasseel Ponche S ^a,b   Ferrapie, A L ^b   Chenet, A ^c   Menei, P ^a,e   Gambart, G ^a,b   Menegalli Bogeli D ^f   Perrouin Verbe, B ^c,d   Gay, S ^g   Richard, I ^a,b  

^a Universite d'Angers   (France)

^b C3RF   (France)

^c CHU DE NANTES   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f CHU de Nantes   (France)

^g Centre de l'Arche 1   (France)

Author keywords

Adult; Caregiver; Cerebral palsy; Intrathecal Baclofen; Spasticity; Wheelchair

Indexed keywords

BACLOFEN;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DYSURIA; FEMALE; HUMAN; INFUSION PUMP; LEG EDEMA; MALE; MOTOR DYSFUNCTION; NURSING CARE; PAIN; PATIENT SATISFACTION; PRURITUS; QUALITY OF LIFE; RETROSPECTIVE STUDY; SALIVATION DISORDER; SPASTICITY; URINE INCONTINENCE; WHEELCHAIR;

ADOLESCENT; ADULT; BACLOFEN; CEREBRAL PALSY; FEMALE; GABA-B RECEPTOR AGONISTS; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; WHEELCHAIRS; YOUNG ADULT;

EID: 77957714045     PISSN: 18770657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rehab.2010.07.007     Document Type: Article

References (73)

1. Albright A.L., Krach L.E., Ivanhoe C.B., McLaughlin J.F. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003, 98:291-295.
2. Albright A.L., Awaad Y., Muhonen M., Boydston W.R., Gilmartin R., Krach L.E., et al. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 2004, 101:64-68.
3. Albright A.L., Barron W.B., Fasick M.P., Polinko P., Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993, 24:2475-2477.
4. Albright A.L., Barry M.J., Shafton D.H., Ferson S.S. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001, 43:652-657.
5. Albright A.L., Ferson S.S. Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. J Neurosurg Pediatr 2009, 3:11-14.
6. Albright A.L. Baclofen in the treatment of cerebral palsy. J Child Neurol 1996, 11:77-83.
7. Andersson C., Mattsson E. Adults with cerebral palsy: a survey describing problems, needs, and resources, with special emphasis on locomotion. Dev Med Child Neurol 2001, 43:76-82.
8. Armstrong R.W., Steinbok P., Cochrane D.D., Kube S.D., Fife S.E., Farrell K. Intrathecally-administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997, 87:409-414.
9. Becker R., Uhle E.I., Alberti O., Bertalanffy H. Continuous intrathecal baclofen infusion in the management of central deafferentation pain. J Pain Symptom Manage 2000, 20:313-315.
10. Becker R., Benes L., Sure U., Hellwig D., Bertalanffy H. Intrathecal baclofen alleviates autonomic dysfonction in severe brain injury. J Clin Neurosci 2000, 7:316-319.
11. Bensmail D., Quera Salva M.A., Roche N., Benyahia S., Bohic M., Denys P., et al. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. Neurology 2006, 67:1432-1436.
12. Bjornson K.F., McLaughlin J.F., Loeser J.D., Nowak-Cooperman K.M., Russel M., Bader K.A., et al. Oral motor, communication, and nutritional status of children during intrathecal baclofen therapy: a descriptive pilot study. Arch Phys Med Rehabil 2003, 8:500-506.
13. Bleyenheuft C., Filipitti P., Caldas C., Lejeune T. Experience with external pump trial to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Neurophysiol Clin 2007, 37:23-28.
14. Borowski A., Shah S.A., Littleton A.G., Dabney K.W., Miller F. Baclofen pump implantation and spinal fusion in children: techniques and complications. Spine 2008, 33:1995-2000.
15. Brochard S., Remy-Neris O., Filipetti P., Bussel B. Intrathecal baclofen infusion for ambulant children with cereral palsy. Pediatr Neurol 2009, 40:265-270.
16. Brzakala V., Debeaumont D., Nedelcu T., Abu Amara S., Vanhulle C., Lechevallier J. Contrôle de la spasticité chez l'enfant infirme moteur cérébral non marchant par la délivrance de baclofène par voie intrathécale. À propos de 11 cas. Rev Chir Orthop Traumatol 2009, 95:101-106.
17. Butler C., Campbell W.M. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 2000, 42:634-645.
18. Caird M.S., Palanca A.A., Garton H., Hensinger R.N., Ayyangar R.N., Drongowski A., et al. Outcomes of posterior spinal fusion and instrumentation in patients with continuous intrathecal baclofen infusion pumps. Spine 2008, 33:94-99.
19. Campbell W.M., Ferrel A., McLaughlin J.F., Grant G.A., Loeser J.D., Graubert C., et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 2002, 44:660-665.
20. Cans C. Epidemiology of cerebral palsy. Mot Cereb Readapt Neurol Dev 2005, 26:51-58.
21. Ceulemans B., van Rhijn J., Kenis S., Krols R., Laridon A., Van Havenbergh T. Opisthotonus and intrathecal treatment with baclofen (ITB) in children. Eur J Pediatr 2008, 167:641-645.
22. Collignon P. The life of handicapped children. Arch Pediatr 2002, 9:1014-1016.
23. Damiano D.L., Quinlivan J.M., Owen B.F., Payne P., Nelson K.C., Abel M.F. What does the Ashworth scale really measure and are instrumented measures more valid and precise?. Dev Med Child Neurol 2002, 44:112-118.
24. Dauvergne F., Gallien P., Eon Y., Nicolas B., Duruflé-Tapin A. Stratégies d'accompagnement des adultes atteints de paralysie cérébrale infantile en Bretagne (APIB), à partir des besoins liés à leur état de santé Mot Cereb Readapt Neurol Dev 2009, 30:57-66.
25. Dralle D., Müller H., Zierski J., Klug N. Intrathecal baclofen for spasticity. Lancet 1985, 326:1003.
26. Ethans K. Intrathecal baclofen therapy: indications, pharmacology, surgical implant, and efficacy. Acta Neurochir Suppl 2007, 97:155-159.
27. Evans P.M., Evans S.J., Alberman E. Cerebral palsy: why we must plan for survival. Arch Dis Child 1990, 65:1329-1333.
28. Gallien P., Nicolas B., Dauvergne F., Pétrilli S., Houedakor J., Roy D., et al. A pain in adults with cerebral palsy. Ann Readapt Med Phys 2007, 50:558-563.
29. Gerszten P.C., Albright A.L., Barry M.J. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 1997, 27:40-44.
30. Gianino J.M., York M.M., Paice J.A., Shott S. Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 1998, 30:47-54.
31. Ginsburg G.M., Lauder A.J. Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. Spine 2007, 32:2745-2750.
32. Houlihan C.M. Walking function, pain, and fatigue in adults with cerebral palsy. Dev Med Child Neurol 2009, 51:338-339.
33. Hoving M.A., Van Raak E.P., Spincemaille G.H., Van Kranen-Mastenbroek V.H., Van Kleef M., Gorter J.W., et al. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol 2009, 13:247-256.
34. Hoving M.A., Evers S.M., Ament A.J., van Raak E.P., Vles J.S. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis. Dev Med Child Neurol 2008, 50:450-455. Dutch Study Group on Child Spasticity.
35. Hutton J.L., Pharoah P.O. Effects of cognitive, motor, and sensory disabilities on survival in cerebral palsy. Arch Dis Child 2002, 86:84-89.
36. Jutand M.A., Gallois A., Léger J., Pambrun E., Rondi F., Belot M., et al. Échelle EDAAP 2: validation statistique d'une grille d'évaluation de l'expression de la douleur chez les adultes ou adolescents polyhandicapés. Mot Cereb Readapt Neurol Dev 2008, 29:93-100.
37. Kolaski K., Logan L.R. A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation 2007, 22:383-395.
38. Koulousakis A., Kuchta J. Intrathecal antispastic drug application with implantable pumps: results of a 10-year follow-up study. Acta Neurochir Suppl 2007, 97:181-184.
39. Krach E.L., Kreil R.L., Gilartin R.C., Swift D.M., Storrs B.B., Abbott R., et al. GMFM 1year after continuous intrathecal baclofen infusion. Pediatr Rehab 2005, 8:207-213.
40. Krach L.E., Kriel R.L., Gilmartin R.C., et al. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. Pediatr Neurol 2004, 30:163-168.
41. Krach L.E., Nettleton A., Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr Rehabil 2006, 9:210-218.
42. Krigger K. Cerebral palsy: an over review. Am Fam Physician 2006, 73:91-100.
43. Latash M.L., Penn R.D. Changes in volonary motor control induced by intrathecal baclofen in patients with spasticity of different etiology. Physiother Res Int 1996, 1:229-246.
44. McCrory P., Turner-Stokes L., Baguley I.J., De Graaff S., Katrak P., Sandanam J., et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med 2009, 41:536-544.
45. Meythaler J.M., Gun-Renfroe S., Law C., Grabb P., Hadley M.N. Continuously infused intrathecal baclofen over 12months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 2001, 82:155-161.
46. Motta F., Buonaguro V., Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 2007, 107:32-35.
47. Narayan R.K., Loubser P.G., Jankovic J., Donovan W.H., Bontke C.F. Intrathecal baclofen for intractable axial dystonia. Neurology 1991, 41:1141-1142.
48. Nemer McCoy R., Blasco P.A., Russman B.S., O'Malley J.P. Validation of a care and comfort hypertonicity questionnaire. Dev Med Child Neurol 2006, 48:181-187.
49. Penn R.D., Gliano J.M., York M.M. Intrathecal baclofen for motor disorders. Mov disord 1995, 10:675-677.
50. Penn R.D., Kroin J.S. Continuous intrathecal baclofen for severe spasticity. Lancet 1985, 20:125-127.
51. Penn R.D., Kroin J.S. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984, 1:1078.
52. Plassat R., Perrouin Verbe B., Menei P., Menegalli D., Mathé J.F., Richard I. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004, 42:686-693.
53. Rawlins P.K. Intrathecal baclofen therapy over 10years. J Neurosci Nurs 2004, 36:322-327.
54. Richard I., Menei P. Intrathecal baclofen in the treatment of spasticity, dystonia and vegetative disorders. Acta Neurochir Suppl 2007, 97:213-218.
55. Sakzewski L., Boyd R., Ziviani J. Clinimetric properties of participation measures for 5- to 13-year-old children with cerebral palsy: a systematic review. Dev Med Child Neurol 2007, 49:232-240.
56. Sallerin B., Lazorthes Y. Intrathecal baclofen. Experimental and pharmacokinetic studies. Neurochirurgie 2003, 49:271-275.
57. Sarà M., Pistoia F., Mura E., Onorati P., Govoni S. Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses. Arch Phys Med Rehabil 2009, 90:1245-1249.
58. Saval A., Chiodo A.E. Effect of intrathecal baclofen concentration on spasticity control: case series. J Spinal Cord Med 2008, 31:394-397.
59. Scheinberg A., Hall K., Lam L.T., O'Flaherty S. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study. J Paediatr Child Health 2006, 42:715-720.
60. Schneider J.W., Gurucharri L.M., Gutierrez A.L., Gaebler-Spira D.J. Health-related quality of life and functional outcome measures for children with cerebral palsy. Dev Med Child Neurol 2001, 43:601-608.
61. Shilt J.S., Lai L.P., Cabrera M.N., Frino J., Smith B.P. The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop 2008, 28:684-687.
62. Singer A.J., Thode H.C. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med 1998, 5:1007-1011.
63. Slonimski M., Abram S.E., Zuniga R.E. Intrathecal baclofen in pain management. Reg Anesth Pain Med 2004, 29:269-276.
64. Steenbeek D., Ketelaar M., Galama K., Gorter J.W. Goal Attainment Scaling in paediatric rehabilitation: a report on the clinical training of an interdisciplinary team. Child Care Health Dev 2008, 34:521-529.
65. No authors listed Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol 2002, 44:633-640. Surveillance of cerebral palsy in Europe (SCPE) collaborative group.
66. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil 2009, 23:362-370.
67. Van Schaeybroeck P., Nuttin B., Lagae L., Schrijvers E., Borghgraef C., Feys P. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 2000, 46:603-609.
68. Vender J.R., Hester S., Waller J.L., Rekito A., Lee M.R. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 2006, 104:9-15.
69. Vidailhet M., Yelnik J., Lagrange C., Fraix V., Grabli D., Thobois S., et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol 2009, 8:709-717.
70. Viehweger E., Robitail S., Rohon M.A., Jacquemier M., Jouve J.L., Bollini G., et al. Measuring quality of life in cerebral palsy children. Ann Readapt Med Phys 2008, 51:119-137.
71. Walker R.H., Danisi F.O., Swope D.M., Goodman R.R., Germano I.M., Brin M.F. Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 2000, 15:1242-1247.
72. Yaksh T.L., Reddy S.V. Studies in the primate on the analgesic effects associated with intrathecal actions of opiate, L-adrenergic agonists and baclofen. Anesthesiology 1981, 54:451-467.
73. Zwakhalen S.M., Hamers J.P., Abu-Saad H.H., Berger M.P. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatr 2006, 27. 6-3.